Recent Examples on the WebLovisa Afzelius, an origination partner at Flagship Pioneering and chief executive of Alltrna, says the company could potentially use a single tRNA drug to treat thousands of diseases that stem from the same genetic mutation.BostonGlobe.com, 9 Nov. 2021